Real Generics infographic on the falsified medicines directive.

Understanding the falsified medicines directive

The falsified medicines directive was published in 2011 with the intention of preventing falsified medicines from entering the pharmaceutical supply chain in the European Economic Area.

We have compiled an infographic that outlines the scope of the directive as well as timelines for implementation – all the information you need, in a nutshell.

You can find the Piktochart infographic here.

It can also be viewed in presentation mode: once you follow the link to the infographic, click on the orange box in the top righthand corner.

 

Real Generics Ltd is a member of the Real Regulatory Group. The partner company, Real Regulatory Ltd, is a consultancy firm specialising in European Regulatory Affairs, Quality Management Systems and Supply Chain Operations Compliance for the pharmaceutical, medical device and aligned industries.

For your regulatory intelligence needs, please do not hesitate to get in touch with us using the contact form.

Trackbacks and pingbacks

No trackback or pingback available for this article.